A carregar...

A comparison of two doses of adriamycin in the primary chemotherapy of disseminated breast carcinoma.

Forty-eight patients with advanced breast carcinoma who had not received prior chemotherapy (minimum follow up 21 months) were randomised to receive either adriamycin 70 mg m-2 i.v. 3-weekly for 8 cycles (Regimen A) or adriamycin 35 mg m-2 i.v. 3-weekly for 16 courses (Regimen B). Objective response...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Carmo-Pereira, J., Costa, F. O., Henriques, E., Godinho, F., Cantinho-Lopes, M. G., Sales-Luis, A., Rubens, R. D.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 1987
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2001830/
https://ncbi.nlm.nih.gov/pubmed/3318902
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!